Midatech Pharma Secures Approval To Commence MTD201 First-Phase Study
(Alliance News) - Midatech Pharma PLC on Friday said it has received approval to start a first phase of study on MTD201, which it is developing for the treatment of acromegaly and neuroendocrine a
Read more